A carregar...
Safety, efficacy, and immunogenicity of Flublok in the prevention of seasonal influenza in adults
Flublok is the first recombinant hemagglutinin (HA) vaccine licensed by the US Food and Drugs Administration for the prevention of influenza in adults aged 18 and older. The HA proteins produced in insect cell culture using the baculovirus expression system technology are exact analogues of wild typ...
Na minha lista:
| Publicado no: | Ther Adv Vaccines |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4591523/ https://ncbi.nlm.nih.gov/pubmed/26478817 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2051013615595595 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|